Innovate or Die: Shorting the Apocalypse Presentations

By Patrick CoxPosted November 19, 2013

Innovate or DiePresentation: Shorting the Apocalypse: Two video presentations, nearly two hours in combined length, filmed at Agora Financial’s $1,000-per-ticket annual Vancouver investment symposium.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Breakthrough Technology Alert

This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.

Patrick Cox

Patrick Cox has lived deep inside transformative technologies for over 25 years. In the 1980s, he worked in software development and manufacturing. By the mid-‘90s, he consulted for Netscape–which handled 90% of all Internet browsing traffic at the time. InfoWorld and USA Today have featured his research, and he’s written for The Wall Street Journal,...

View More By Patrick Cox

Video Gaming Continues to Yield Enormous Profits

By Patrick CoxPosted March 4, 2008

I watch the video game industry closely, for several reasons. One is straightforward and simple. It's huge and growing furiously. Hollywood is pretending otherwise, but gaming today is a bigger industry than the movie business.

Alzheimer’s Therapy Moves Closer to Human Trials

By Ray BlancoPosted June 18, 2018

Everyday doctors strive to find an Alzheimer’s cure, and the search for answers advanced last week. Ray has everything you need to know about one breakthrough Alzheimer’s therapy…

FDA’s Breakthrough Therapies Pathway Will Benefit Breakthrough Technology Alert Portfolio

By Patrick CoxPosted April 2, 2013

Recovery from my eye surgeries is going very well, though it's going to take weeks for my vision to stabilize. Because my vision is in flux, my surgeon has convinced me that I should wait before buying even temporary glasses, which is somewhat uncomfortable. Fortunately, I'm corrected to reading distance, but driving and such is out of the question. I am convinced, incidentally, that my rate of healing is a result of Star Scientific's Anatabloc. I had oral surgery a few years ago, and my recovery was painfully slow, unlike my current experience. Regardless, I used my somewhat impaired eyesight as an excuse not to work this weekend.

New Delivery Technology Delivers Amazing Results, And One Company Achieves NYSE Listing

By Ray BlancoPosted September 24, 2013

It's been an epic week on the frontiers of gene therapy. Two of our gene pioneers have important news on their clinical programs. In no particular order, let's take a look at what's going on with the first. By now the market is finally starting to wake up to the possibilities of RNA interference (RNAi) as a way to treat genetic disease….

The Party Has Just Begun

By Stephen PetranekPosted December 29, 2014

Of the 13 picks I’ve made in the last 14 months, only one is down by any significant amount. Meanwhile, one of my recommendations has quadrupled, one is close to tripling and three are close to doubling. Five more are up 10-50%. I think 2015 will be a very good year for our portfolio, perhaps even better than 2014.

A New Biotech Crawls Into This Biotech’s Shell

By Stephen PetranekPosted November 23, 2015

Just days after I wrote to you last week to hold your shares of this biotech company in our portfolio in hopes of a reverse merger, it happened. Now we have some hope.